Monoethanolamine

Monoethanolamine

SCHEMBL3973136

CC(C)(O)C(=O)c1ccc(CCO)cc1.NCCO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 5/20 0.45
CYP4F2 P78329 4/20 0.45
PPARA Q07869 2/20 0.44
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
CA12 O43570 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
DHODH Q02127 3/20 0.38
ESRRG P62508 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL154857 0.93 CYP4A11 (0.50) CYP4A11CYP4F2PPARACA2CA1
SCHEMBL9808692 0.88 TAAR1 (0.45) CA2CA1CA12CA4CA6
SCHEMBL9808660 0.85 ESR1 (0.45) CYP4A11CYP4F2ESRRG
SCHEMBL3687860 0.84 PLK1 (0.41) CYP4A11CA2ESRRG
SCHEMBL9808693 0.83 CYP4A11 (0.57) CYP4A11CYP4F2PPARACA2ESRRG
SCHEMBL28584026 0.79 CYP4A11 (0.47) CYP4A11CYP4F2PPARACA2CA1
SCHEMBL1060928 0.79 PLK1 (0.55) TDP1
SCHEMBL480503 0.78 EPHX2 (0.49) PPARACA2CA1CA12CA4
SCHEMBL3976669 0.77 KMT2A (0.47) CYP4A11ESRRGTDP1
SCHEMBL153898 0.76 KMT2A (0.56) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367743-B2 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces BASF SE (DE) 2013-02-05 US disclosed
US-20090104464-A1 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces IGM GROUP B.V. (NL) 2009-04-23 US disclosed
WO-2009050116-A2 ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES BASF SE (DE) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104464-A1 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces CDH1, PCNA, VCAM1 CYP4A11 4662/4885CYP4F2 3785/4885PPARA 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.